Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
Formula One : United States Grand Prix – live updates
19/10/2025
Israel says it has resumed enforcement of ceasefire after wave of airstrikes on Gaza – Middle East crisis live
19/10/2025
MPs urged to confront royal family over Prince Andrew’s Epstein links
19/10/2025
England invite Noah Caluori to training after sparkling five-try Prem debut
19/10/2025
Defensive woes a bigger headache for Slot than getting Isak and Salah to fire | Andy Hunter
19/10/2025
Dead fish found on River Thet where large stretch of white foam appeared
19/10/2025